SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Romania
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Crida Pharm

Main Activities: Pharmaceutical and Medicine Manufacturing

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Crida Pharm SRL

Headquarters
2, Intrarea Vagonetului; BUCURESTI; Bucharest; 61151
Status: Non-Listed
Legal Form: Limited Liability Company
Operational Status: Operational
CUI: 09602646
Incorporation Date: January 1, 1997
Total Employees: 28

Tel: 00 40-21-430.4399;+40-21-251.5005

Company Description

Crida Pharm SRL company operates on the Romanian market since 1997. The main activity of the company is Manufacture of pharmaceuticals products, and the company operates mostly in Bucharest.

Company Analysis

According to the Individual - Non-Audited financial statement for the Year of 2010, total net operating revenues increased with 4.05%, from RON 18,858,393 to RON 19,621,308 . Operating result increased from RON 1,725,237 to RON 2,864,767 which means 66.05% change. The results of the period increased 95.56% reaching RON 2,431,506 at the end of the period against RON 1,243,349 last year. Return on equity (Net income/Total equity) went from 57.65% to 61.42%, the Return On Asset (Net income / Total Asset) went from 17.13% to 24.14% and the Net Profit Margin (Net Income/Net Sales) went from 6.59% to 12.39% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 154.45% compared to 236.55% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 0.87 to 1.06 when compared to the previous year.

Key Executives

Gheorghe Paraschiv General Manager
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

10,435,783

10,112,177

Current Assets

X,XXX,XXX

X,XXX,XXX

Total Liabilities

X,XXX,XXX

X,XXX,XXX

Shareholders Equity

X,XXX,XXX

X,XXX,XXX

Current Liabilities

X,XXX,XXX

X,XXX,XXX

* All the accounts are in RON.
Income Statement

Total Operating Revenue

XX,XXX,XXX

X,XXX,XXX

Operational Profit (Loss)

X,XXX,XXX

XXX,XXX

Net Profit (Loss)

X,XXX,XXX

XXX,XXX

* All the accounts are in RON.
Ratios
Profitability Ratios

Return on Assets (ROA)

XX.XX%

X.XX%

Annualised Return on Assets (ROA)

XX.XX%

X.XX%

Return on Equity (ROE)

XX.XX%

XX.XX%

Annualised Return on Equity (ROE)

XX.XX%

XX.XX%

Return on Sales (ROS)

X.XX%

X.XX%

Return on Capital

XX.XX%

XX.XX%

Gross Profit Margin

XX.XX%

XX.XX%

Operating Profit Margin

XX.XX%

X.XX%

Efficiency Ratios

Accounts Receivable Turnover

X.XXx

X.XXx

Inventory Turnover

X.XXx

X.XXx

Current asset turnover

X.XXx

X.XXx

Fixed-asset turnover

X.XXx

X.XXx

Asset Turnover

X.XXx

X.XXx

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

X,XXX,XXX

XXX,XXX

EBITDA

X,XXX,XXX

XXX,XXX

Bookvalue (BV)

X,XXX,XXX

X,XXX,XXX

Net Cash

-X,XXX,XXX

-X,XXX,XXX

Liquidity Ratios

Current Ratio

XXX.XX%

XX.XX%

Quick ratio

XX.XX%

XX.XX%

Doom's day ratio

X.XX%

X.XX%

Leverage Ratios

Leverage ratio

XXX.XX%

XXX.XX%

Interest Coverage Ratio

X.XX%

X.XX%

Debt to equity

XXX.XX%

XXX.XX%

Debt to total assets

XX.XX%

XX.XX%

Long Term Debt to Capital

X%

XX.XX%